What is PreemptiveAI?
Founded in 2022 and headquartered in Seattle, Washington, PreemptiveAI is developing a foundational model designed to map human physiology and pathology. The company's innovative approach aims to predict health outcomes in real-time by analyzing biomedical signals captured from smartphones and wearable devices. This focus on predictive health analytics positions PreemptiveAI at the intersection of AI, health tech, and personalized medicine.
How much funding has PreemptiveAI raised?
PreemptiveAI has raised a total of $6.4M across 1 funding round:
Other Financing Round
$6.4M
Other Financing Round (2024): $6.4M with participation from Precursor Ventures, Inspired Capital, and Meridian Street Capital
Key Investors in PreemptiveAI
Precursor Ventures
Precursor Ventures is a venture capital firm specializing in pre-seed and seed stage investments, with a focus on backing founders early in their entrepreneurial journey.
Inspired Capital
Inspired Capital is a generalist venture capital fund that leads early-stage investment rounds, supporting ambitious founders across various sectors including AI transformation and healthcare.
Meridian Street Capital
Meridian Street Capital is a closely held investment fund that partners with entrepreneurs to facilitate business growth and development.
What's next for PreemptiveAI?
The recent major strategic investment signals a pivotal moment for PreemptiveAI, likely enabling the company to accelerate its product development, scale its operations, and expand its market reach. This enterprise-level funding suggests a transition towards broader commercialization and strategic partnerships, aiming to solidify its position in the rapidly evolving health technology landscape. Future growth will likely involve further refinement of its predictive algorithms and integration with healthcare systems.
See full PreemptiveAI company page
